Advertisement

Topics

Shionogi Deal Opens Asia To Sage’s Fast-Acting Antidepressant

21:35 EDT 13 Jun 2018 | SCRIP

Japan’s Shionogi has gained selected Asian rights to Sage’s promising fast-acting depression drug, in a deal worth up to $575m...

      

Related Stories

 

Original Article: Shionogi Deal Opens Asia To Sage’s Fast-Acting Antidepressant

NEXT ARTICLE

More From BioPortfolio on "Shionogi Deal Opens Asia To Sage’s Fast-Acting Antidepressant"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Depression
Depression is a serious mental health condition, where sad feelings carry on for weeks or months and interfere with your life. The symptoms include feeling unhappy most of the time (but may feel a little better in the evenings), loosing interest in lif...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...